Quantification of AICAR-ribotide concentrations in red blood cells by means of LC-MS/MS Anti-doping Analysis

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 30, 2013, Pages 9703-9709

  Thomas, Andreas ^a   Vogel, Matthias ^a   Piper, Thomas ^a   Krug, Oliver ^a   Beuck, Simon ^a   Schänzer, Wilhelm ^a   Thevis, Mario ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Doping; Erythrocyte; Mass spectrometry; Sport

Indexed keywords

ANALYTICAL METHOD; ERYTHROCYTE; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; PHYSICAL EXERCISE; PHYSIOLOGICAL LEVELS; QUALITATIVE ANALYSIS; QUANTITATIVE RESULT; SPORT;

CELLS; DOPING (ADDITIVES); LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SPORTS;

BLOOD;

5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; BIOLOGICAL MARKER; DRUG DERIVATIVE; PERFORMANCE ENHANCING SUBSTANCE; RIBONUCLEOTIDE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHEMISTRY; CHILD; DOPING; ERYTHROCYTE; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METHODOLOGY; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ADOLESCENT; ADULT; AMINOIMIDAZOLE CARBOXAMIDE; BIOLOGICAL MARKERS; CHILD; CHROMATOGRAPHY, LIQUID; DOPING IN SPORTS; ERYTHROCYTES; FEMALE; HUMANS; MALE; PERFORMANCE-ENHANCING SUBSTANCES; RIBONUCLEOTIDES; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84890124526     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-7162-0     Document Type: Article

References (19)

1. Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, Mihaylova MM, Nelson MC, Zou Y, Juguilon H, Kang H, Shaw RJ, Evans RM (2008) Cell 134:405-415
2. Thevis M, Thomas A, Kohler M, Beuck S, Schänzer W (2009) J Mass Spectrom 44:442-460
3. Been J (2012) Velonation: http://www.velonation.com/News/ID/11395/Doping- AICAR-Telmisartan-and-the-need-for-vigilance.aspx#post-comments. Accessed 22 Apr 2013
4. Stokes S (2012) Velonation: http://www.velonation.com/News/ID/11406/ Colombian-doctor-Beltran-Nino-arrested-with-AICAR-and-TB-500-doping-products. aspx. Accessed 22 Apr 2013
5. http://www.wada-ama.org/en/Science-Medicine/Prohibited-List/ (2013), Vol. 2013
6. Barre L, Richardson C, Hirshman MF, Brozinick J, Fiering S, Kemp BE, Goodyear LJ, Witters LA (2007) Am J Physiol Endocrinol Metab 292:E802-E811
7. Goodyear LJ (2008) N Engl J Med 359:1842-1844
8. Marie S, Heron B, Bitoun P, Timmerman T, Van Den Berghe G, Vincent MF (2004) Am J Hum Genet 74:1276-1281
9. Dixon R, Fujitaki J, Sandoval T, Kisicki J (1993) J Clin Pharmacol 33:955-958
10. Dixon R, Gourzis J, McDermott D, Fujitaki J, Dewland P, Gruber H (1991) J Clin Pharmacol 31:342-347
11. Thomas A, Beuck S, Eickhoff JC, Guddat S, Krug O, Kamber M, Schänzer W, Thevis M (2010) Anal Bioanal Chem 396:2899-2908
12. Bosselaar M, Smits P, van Loon LJ, Tack CJ (2011) J Clin Pharmacol 51(10):1499-58
13. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Anal Chem 75:3019-3030
14. Trufelli H, Palma P, Famiglini G, Cappiello A (2011) Mass Spectrom Rev 30:491-509
15. Guddat S, Solymos E, Orlovius A, Thomas A, Sigmund G, Geyer H, Thevis M, Schanzer W (2011) Drug Test Anal 3:836-850
16. Thomas A, Schänzer W, Delahaut P, Thevis M (2012) Methods 56:230-235
17. Thomas A, Geyer H, Schänzer W, Crone C, Kellmann M, Moehring T, Thevis M (2012) Anal Bioanal Chem 403:1279-1289
18. Kohler M, Thomas A, Walpurgis K, Schänzer W, Thevis M (2010) Anal Bioanal Chem 398:1305-13012
19. Saugy M, Robinson N, Saudan C (2009) Drug Test Anal 1:474-478